EIF2AK2 and cancer: Furthermore, increased expression of a subset of ISGs, including IFITM1, EIF2AK2, STAT1, and IFI27, has been reported in several types of cancers, and these ISGs have been shown to promote tumor growth and resistance to chemotherapy and radiotherapy [11, 37, 38].